Core Insights - China Feihe has launched the country's first comprehensive database for human milk oligosaccharides (HMOs), addressing long-standing challenges in detection and application within the industry, and marking a new era in precise analysis of human milk in China [1] - The project is part of the "14th Five-Year Plan" national key research and development initiative, focusing on the creation of a new generation of infant formula tailored to Chinese babies [1][4] - Feihe has established a maternal and child health cohort, utilizing advanced research methods to decode the nutritional components of Chinese breast milk, which will support the development of localized infant formula standards [3][4] Research and Development Achievements - Feihe has invested nearly 100 million yuan in collaboration with five universities and 15 national platforms, creating a robust research team for maternal milk studies [1][3] - The company has achieved significant breakthroughs in analyzing key nutritional components of Chinese breast milk, including proteins and HMOs, and has established a proprietary intellectual property system for breast milk research [4][8] - Feihe's innovative use of AI and big data in research has positioned it at the forefront of global breast milk studies, allowing for a deeper understanding of the interactions between milk components and their effects on infant health [6][8] Product Innovation and Market Position - The "14th Five-Year Plan" project aims to enhance the activity of key functional ingredients in infant formula, achieving over a 20% improvement in the activity of lactoferrin and a 30% increase in its solubility [9] - Feihe has developed a large-scale automated production line for lactoferrin, reducing reliance on imports and enhancing domestic production capabilities [9] - The company has maintained its position as the top seller of infant formula in China for six consecutive years and globally for four years, showcasing the competitiveness of China's dairy industry [11] Future Directions - Feihe plans to continue leveraging its maternal and child health cohort to refine and develop new generations of infant formula, integrating cloud computing and AI algorithms to create a comprehensive data center for Chinese breast milk [11]
“母乳研究国家队”再传捷报！飞鹤牵头“十四五”重点专项获阶段性新突破